Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis.

Protogerou AD, Zampeli E, Fragiadaki K, Stamatelopoulos K, Papamichael C, Sfikakis PP.

Atherosclerosis. 2011 Dec;219(2):734-6. doi: 10.1016/j.atherosclerosis.2011.09.015. Epub 2011 Sep 16.

PMID:
21968316
2.

Sleep disturbances and interleukin 6 receptor inhibition in rheumatoid arthritis.

Fragiadaki K, Tektonidou MG, Konsta M, Chrousos GP, Sfikakis PP.

J Rheumatol. 2012 Jan;39(1):60-2. doi: 10.3899/jrheum.110617. Epub 2011 Dec 1.

PMID:
22133618
3.

Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis.

Kerekes G, Soltész P, Szucs G, Szamosi S, Dér H, Szabó Z, Csáthy L, Váncsa A, Szodoray P, Szegedi G, Szekanecz Z.

Isr Med Assoc J. 2011 Mar;13(3):147-52.

4.

Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy.

Mäki-Petäjä KM, Hall FC, Booth AD, Wallace SM, Yasmin, Bearcroft PW, Harish S, Furlong A, McEniery CM, Brown J, Wilkinson IB.

Circulation. 2006 Sep 12;114(11):1185-92. Epub 2006 Sep 4.

5.

Interleukin 6 as therapeutic target in athero-/arteriosclerosis--small steps towards a new treatment paradigm in cardiovascular disease?

Henry RM.

Atherosclerosis. 2011 Dec;219(2):390-1. doi: 10.1016/j.atherosclerosis.2011.07.102. Epub 2011 Jul 28. No abstract available.

PMID:
21840523
6.

Tetrahydrobiopterin Supplementation Improves Endothelial Function But Does Not Alter Aortic Stiffness in Patients With Rheumatoid Arthritis.

Mäki-Petäjä KM, Day L, Cheriyan J, Hall FC, Östör AJ, Shenker N, Wilkinson IB.

J Am Heart Assoc. 2016 Feb 19;5(2). pii: e002762. doi: 10.1161/JAHA.115.002762.

7.

Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis.

Marder W, Khalatbari S, Myles JD, Hench R, Yalavarthi S, Lustig S, Brook R, Kaplan MJ.

Ann Rheum Dis. 2011 Sep;70(9):1550-5. doi: 10.1136/ard.2010.148031. Epub 2011 Jul 4.

9.

The peroxisome proliferator activated receptor-γ pioglitazone improves vascular function and decreases disease activity in patients with rheumatoid arthritis.

Marder W, Khalatbari S, Myles JD, Hench R, Lustig S, Yalavarthi S, Parameswaran A, Brook RD, Kaplan MJ.

J Am Heart Assoc. 2013 Nov 19;2(6):e000441. doi: 10.1161/JAHA.113.000441.

10.

Clinical pharmacology of tocilizumab for the treatment of patients with rheumatoid arthritis.

Zhang X, Peck R.

Expert Rev Clin Pharmacol. 2011 Sep;4(5):539-58. doi: 10.1586/ecp.11.33. Review.

PMID:
22114882
11.

Inhibiting interleukin-6 in rheumatoid arthritis.

Choy E.

Curr Rheumatol Rep. 2008 Oct;10(5):413-7.

PMID:
18817647
12.

Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy.

Snir A, Kessel A, Haj T, Rosner I, Slobodin G, Toubi E.

Clin Exp Rheumatol. 2011 Jul-Aug;29(4):697-700. Epub 2011 Sep 1.

PMID:
21813064
13.

Safety of subcutaneous versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.

McLaughlin M, Östör A.

Expert Opin Drug Saf. 2015 Mar;14(3):429-37. doi: 10.1517/14740338.2015.998198. Epub 2015 Jan 2. Review.

PMID:
25553607
14.
15.

Impact of IL-6 receptor inhibition on human memory B cells in vivo: impaired somatic hypermutation in preswitch memory B cells and modulation of mutational targeting in memory B cells.

Muhammad K, Roll P, Seibold T, Kleinert S, Einsele H, Dörner T, Tony HP.

Ann Rheum Dis. 2011 Aug;70(8):1507-10. doi: 10.1136/ard.2010.141325. Epub 2011 May 8.

PMID:
21551509
16.

Endothelial dysfunction and the effects of TNF inhibitors on the endothelium in psoriasis and psoriatic arthritis: a systematic review.

Brezinski EA, Follansbee MR, Armstrong EJ, Armstrong AW.

Curr Pharm Des. 2014;20(4):513-28. Review.

PMID:
23565632
17.

Serious herpes zoster in rheumatoid arthritis under anti-interleukin-6 receptor antibody.

Kubandova Z, Mathieu S, Pourtier C, Soubrier M.

Joint Bone Spine. 2010 Dec;77(6):623-4. doi: 10.1016/j.jbspin.2010.07.009. Epub 2010 Sep 18. No abstract available.

PMID:
20851657
18.
19.
20.

Interleukin-6: a new therapeutic target.

Smolen JS, Maini RN.

Arthritis Res Ther. 2006;8 Suppl 2:S5. Epub 2006 Jul 28. Review. Erratum in: Arthritis Res Ther. 2006;8(6):407.

Supplemental Content

Support Center